MedPath

Art Therapy and Music Reminiscence Activity in the Prevention of Cognitive Decline

Not Applicable
Completed
Conditions
Mild Cognitive Impairment
Interventions
Behavioral: Art Therapy
Behavioral: Music Reminiscence Activity
Registration Number
NCT02854085
Lead Sponsor
National University of Singapore
Brief Summary

The objective of this study is to determine the impact of Art Therapy and Music Reminiscence Activity on cognition in community living elderly with Mild Cognitive Impairment (DSM V: Mild Neurocognitive Disorder) using a randomized control design.

Specifically, the structural cerebral changes that occur with the two interventions and the extent to which the therapies may reverse cognitive impairment and/or prevent further cognitive decline, will be determined.

The hypothesis is that participants in both active intervention arms will perform better on neuropsychological tests of cognition and will show positive changes on functional imaging studies compared to controls who will not receive any intervention. Participants in the interventions will also have positive changes in blood biomarkers, enhanced psychological well-being and reductions in anxiety and depressive symptoms compared to the control group. No a priori hypotheses were developed as to whether Art Therapy or Music Reminiscence Activity is more effective as the comparison is exploratory.

Detailed Description

Participants: 90 community-living elderly, with mild cognitive impairment.

Interventions: Participants will be randomized into 3 arms: Art Therapy, Music Reminiscence Activity or a Control arm. Sessions will be conducted weekly for 3 months and fortnightly for 6 months. Each intervention session will last for 40 minutes. The Control group will not receive any intervention and continue their life as usual.

Assessments: Demographic data will be collected at baseline. Neuropsychological tests of cognitive functioning will be done at baseline, 3 months and 9 months. Anxiety and depressive symptoms will be assessed at the 3 time-points. Blood sampling will occur at all time points (except control group, only at baseline and 9 months). Participants will also undergo a task-free brain fMRI scan at baseline and at 3 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
68
Inclusion Criteria
  • Older person between 60 and 85 years of age, living in the community and fulfills the operational criteria/definition of MCI:

    1. At least one age-education adjusted neuropsychological test Z score <-1.5
    2. Do not meet DSM V criteria for a Major Neurocognitive Disorder
    3. Memory/Cognitive complaint preferably corroborated by a reliable informant
    4. Intact Activities of Daily Living
  • Functions independently

  • Does not have dementia

  • Able to travel to the data collection site on their own and participate in the activity

Exclusion Criteria
  • Those who do not meet the above inclusion criteria (ie. do not have a MCI diagnosis)
  • Those with Dementia/Major Neurocognitive Disorder or Normal Ageing
  • Presence of a neurological condition e.g. epilepsy, Parkinson Disease, stroke
  • Presence of a major psychiatric disorder e.g. Major Depression, Psychoses
  • Terminal illness e.g. cancer
  • Presence of significant visual and/or hearing impairment and Color Blindness
  • Participants in another intervention study at the same time

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Art TherapyArt TherapyArt Therapy, 24 sessions
Music Reminiscence ActivityMusic Reminiscence ActivityMusic Reminiscence Activity, 24 sessions
Primary Outcome Measures
NameTimeMethod
Neuropsychological Test: Change from baseline in Digit Span Task scores at 3 months and 9 monthsMeasured at Baseline, 3 months and 9 months

Digit Span Task \[(Digit Span Forward (DSF) and Digit Span Backward (DSB)\]

DSF Measure: 1 point for each correct sub-item response, Minimum: 0; Maximum 16 DSB Measure: 1 point for each correct sub-item response, Minimum: 0; Maximum 14

Neuropsychological Test: Change from baseline in Colour Trails Test scores at 3 months and 9 monthsMeasured at Baseline, 3 months and 9 months

Colour Trails Test (CTT) 1 and 2

Measure: Time to completion, in seconds for Trial 1 and Trial 2. Time Limit: 240s

Change from baseline fMRI scan at 3 monthsMeasured at Baseline and 3 months

Task-free Functional Magnetic Resonance Imaging (fMRI) will be employed to examine changes in functional connectivity.

Neuropsychological Test: Change from baseline in Rey Auditory Verbal Learning Test scores at 3 months and 9 monthsMeasured at Baseline, 3 months and 9 months

Measure: Number of items from a list of 15 items participant is able to recall immediately and 30 minutes later.

Neuropsychological Test: Change from baseline in Block Design Test scores at 3 months and 9 monthsMeasured at Baseline, 3 months and 9 months

Block Design (sub-test of the Wechsler Adult Intelligence Scale Tests)

Measure: Respective sub-item test scores, based on time of completion and accuracy; Maximum score: 68

Secondary Outcome Measures
NameTimeMethod
Change from baseline telomere lengths at 3 months and 9 monthsMeasured at Baseline, 3 months and 9 months

Blood investigations to detect changes in telomere length

Trial Locations

Locations (1)

Training and Research Academy

🇸🇬

Singapore, Singapore

Training and Research Academy
🇸🇬Singapore, Singapore
© Copyright 2025. All Rights Reserved by MedPath